(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(-0.08%) $78.94
(5.43%) $2.04
(0.09%) $2 313.10
(0.47%) $26.88
(0.76%) $962.15
(-0.08%) $0.932
(-0.34%) $10.99
(-0.10%) $0.798
(-1.35%) $92.01
5 days till quarter result
(bmo 2024-05-07)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Techno Medica Co., Ltd. engages in the research and development, manufacture, sale, import, and export of in-vitro diagnostic analyzers in Japan. The company offers test tube preparation, automatic urine aliquot, RFID specimen management, and RFID blood transfusion management, as well as blood gas, electrolyte, Erythrocyte Sedimentation Rate, nutrient, sugar and acid, and urine chemistry analyzers; electronic medical charts and pre-analytical instruments; and consumables and after sales services...
Stats | |
---|---|
Šios dienos apimtis | 3 000.00 |
Vidutinė apimtis | 10 081.00 |
Rinkos kapitalizacija | 12.09B |
EPS | ¥0 ( 2024-02-07 ) |
Kita pelno data | ( ¥0 ) 2024-05-07 |
Last Dividend | ¥60.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 11.57 |
ATR14 | ¥2.78 (0.16%) |
Techno Medica Co., Ltd. Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Techno Medica Co., Ltd. Finansinės ataskaitos
Annual | 2022 |
Pajamos: | ¥9.37B |
Bruto pelnas: | ¥4.63B (49.43 %) |
EPS: | ¥136.35 |
FY | 2022 |
Pajamos: | ¥9.37B |
Bruto pelnas: | ¥4.63B (49.43 %) |
EPS: | ¥136.35 |
FY | 2022 |
Pajamos: | ¥9.70B |
Bruto pelnas: | ¥4.82B (49.67 %) |
EPS: | ¥150.85 |
FY | 2021 |
Pajamos: | ¥9.04B |
Bruto pelnas: | ¥4.45B (49.27 %) |
EPS: | ¥135.78 |
Financial Reports:
No articles found.
Techno Medica Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥0 (N/A) |
¥60.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥24.67 | 2007-03-27 |
Last Dividend | ¥60.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 20 | -- |
Total Paid Out | ¥721.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.05 | -- |
Div. Sustainability Score | 6.10 | |
Div.Growth Potential Score | 2.89 | |
Div. Directional Score | 4.49 | -- |
Year | Amount | Yield |
---|
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8331.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7717.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6871.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
6245.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4967.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
4172.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
3355.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
2429.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
9936.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8955.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.127 | 1.500 | 7.47 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0791 | 1.200 | 7.36 | 8.83 | [0 - 0.3] |
returnOnEquityTTM | 0.0816 | 1.500 | -0.204 | -0.306 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 6.40 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 4.87 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 3.89 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | -0.00664 | -1.500 | -0.111 | 0.166 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 28.40 | 2.00 | 0.532 | 1.064 | [0 - 30] |
freeCashFlowPerShareTTM | 28.40 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | -0.00781 | -1.500 | -0.0312 | 0.0469 | [0 - 2.5] |
grossProfitMarginTTM | 0.499 | 1.000 | 5.01 | 5.01 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.180 | 1.000 | 8.40 | 8.40 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -2.17 | 1.000 | -10.00 | -10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.624 | 0.800 | 9.17 | 7.34 | [0.5 - 2] |
Total Score | 6.10 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 11.10 | 1.000 | 8.98 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0816 | 2.50 | -0.131 | -0.306 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 28.40 | 2.00 | 0.532 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.17 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 28.40 | 2.00 | 0.532 | 1.064 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.000 | 1.500 | 6.67 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0231 | 1.000 | -1.924 | 0 | [0.1 - 0.5] |
Total Score | 2.89 |
Techno Medica Co., Ltd.
Techno Medica Co., Ltd. engages in the research and development, manufacture, sale, import, and export of in-vitro diagnostic analyzers in Japan. The company offers test tube preparation, automatic urine aliquot, RFID specimen management, and RFID blood transfusion management, as well as blood gas, electrolyte, Erythrocyte Sedimentation Rate, nutrient, sugar and acid, and urine chemistry analyzers; electronic medical charts and pre-analytical instruments; and consumables and after sales services. Techno Medica Co., Ltd. was incorporated in 1987 and is headquartered in Yokohama, Japan.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.